SERPATE Drug Patent Profile
✉ Email this page to a colleague
When do Serpate patents expire, and what generic alternatives are available?
Serpate is a drug marketed by Vale and is included in one NDA.
The generic ingredient in SERPATE is reserpine. There is one drug master file entry for this compound. Additional details are available on the reserpine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SERPATE?
- What are the global sales for SERPATE?
- What is Average Wholesale Price for SERPATE?
Summary for SERPATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 393 |
| DailyMed Link: | SERPATE at DailyMed |
US Patents and Regulatory Information for SERPATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vale | SERPATE | reserpine | TABLET;ORAL | 009453-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vale | SERPATE | reserpine | TABLET;ORAL | 009453-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
